R, P. and Bashir, S. 2016. CRITICAL REVIEW OF PHARMACOGENOMICS IN ANTIPARKINSONIAN DRUG THERAPY: IMPACT ON CLINICAL MANAGEMENT OF PARKINSON’S DISEASE. Asian Journal of Pharmaceutical and Clinical Research. 9, 6 (Nov. 2016), 24–27. DOI:https://doi.org/10.22159/ajpcr.2016.v9i6.13350.